'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
'医疗保险现在可以覆盖Eli Lilly的Zepbound用于睡眠呼吸暂停,康哲药业表示' - CNBC
Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC.
That opens the door for broader coverage of and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss specifically.
Medicare Part D plans can cover obesity drugs if they are used for an additional medically accepted purpose approved by the Food and Drug Administration.
医疗保险药物计划现在可以覆盖艾 Eli Lilly 的重磅减肥药物 Zepbound 用于阻塞性睡眠 apnea,医疗保险和医疗补助服务中心向 CNBC 确认。
这为更广泛的覆盖和获取 Zepbound 打开了大门,Zepbound 目前未被医疗保险和许多其他保险计划为减肥特别覆盖。
如果医疗保险部分 D 计划用于获得食品与药物管理局批准的额外医学认可的用途,则可覆盖减肥药。
Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on...
医疗保险药物计划现在可以覆盖艾 Eli ...
登录免费看全文
登录/注册